CytomX Therapeutics, Inc. (CTMX) NASDAQ
3.16
-0.29(-8.41%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 587.61M |
| Enterprise Value | 579.18M |
| P/E Ratio | -9.47 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 14.3 |
| Price/Book Ratio | 1.75 |
| Enterprise/Revenue | 13.57 |
| Enterprise/EBITDA | -7.8 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -1.66 |
| Operating Margin | -1.82 |
Management Effectiveness
| Return On Assets | -0.16 |
| Return On Equity | -0.37 |
Income Statement
| Revenue | 76.2M |
| Revenue/Share | 0.2 |
| Gross Profit | 76.2M |
| EBITDA | -20.99M |
| Net Income | -17.37M |
| Diluted EPS | -0.15 |
Balance Sheet
| Total Cash | 346.71M |
| Total Cash/Share | 1.96 |
| Total Debt | 2.86M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 10.38 |
| Book Value Per Share | 1.8 |
Price History
| 52-Week Change | 25.9 |
| 52-Week High | 8.21 |
| 52-Week Low | 1.72 |
| Moving Average 50 Days | 4.16 |
| Moving Average 200 Days | 4 |
Statistics
| Average Volume | 6.86M |
| Shares Outstanding | 160.82M |
| % Held by Institutions | 140.04 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
